Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

sales@dingminpharma.com

86-311-67591193

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
HomeProductsAPIs And IntermediatesAPIs PowderDabrafenib Mesylate Powder CAS No.1195768-06-9

Dabrafenib Mesylate Powder CAS No.1195768-06-9

  • $1
    ≥1
    Gram
Payment Type:
L/C,T/T,Paypal,Others
Incoterm:
FOB,CFR,CIF,CPT
Min. Order:
1 Gram
Transportation:
Ocean,Air,Express,Others
Port:
Shanghai ,Guangzhou ,Shenzhen
Share:
  • Product Description
Overview
Product Attributes

Model No.DM 1195768-06-9

Purity99.0%+

AppearanceOff-white to white powder

Supply Ability & Additional Information

PackagingDouble PE with Foil Bag

ProductivityStock Available

TransportationOcean,Air,Express,Others

Place of OriginHebei,China

CertificateISO9001

PortShanghai ,Guangzhou ,Shenzhen

Payment TypeL/C,T/T,Paypal,Others

IncotermFOB,CFR,CIF,CPT

Packaging & Delivery
Selling Units:
Gram
Package Type:
Double PE with Foil Bag

PRODUCT DETAILS

Name: Dabrafenib Mesylate

CAS NO.1195768-06-9 

Other Name:Dabrafenib Mesylate (GSK-2118436);Dabrafenib Mesylate(GSK-2118436B);Dabrafenib Mesylate;GSK 2118436 Mesylate;GSK 2118436B;GSK2118436 Mesylate;GSK-2118436 Mesylate;Dabrafenib Mesylate (API)
Appearance:Off-white to white powder

Purity:99.0%+


Package&Shipping

Package:Double PE Bag with Foil Bag or As Required

Delivery time:Stock Available

Port:Any port in China

Product Categories : APIs And Intermediates > APIs Powder

Email to this supplier
  • *Subject:
  • *To:
    Ms. Lily
  • *Email:
  • *Message:
    Your message must be between 20-8000 characters
HomeProductsAPIs And IntermediatesAPIs PowderDabrafenib Mesylate Powder CAS No.1195768-06-9
Send Inquiry
*
*

Related Products List

Home

Product

Phone

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send